Check out the companies making headlines in midday trading: Boeing — The aerospace giant fell 1.5% even after noting that it burned
Tag: Biogen Inc
Eli Lilly hits another Alzheimer’s hurdle. But obesity, diabetes GLP-1s strong
Eli Lilly ‘s experimental Alzheimer’s treatment hit another hurdle with U.S. drug regulators. It pushed out the timeline for potential approval but
Eli Lilly Alzheimer’s drug FDA approval delayed
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading
The Nasdaq’s most beloved stocks that are expected to rally
Even as the Nasdaq Composite is surging to new highs, investors can still find stocks within the index that have room to
Biogen drops Alzheimer’s drug Aduhelm to focus on Leqembi, others
The Biogen headquarters in Cambridge, Massachusetts, on Oct. 24, 2023. Vanessa Leroy | Bloomberg | Getty Images Biogen on Wednesday said it
All the market-moving chatter from Wall Street Wednesday morning
(This is CNBC Pro’s live coverage of Wednesday’s analyst calls and Wall Street chatter. Please refresh every 20-30 minutes to view the
Where M&A could be heading in the obesity drug space
Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly
Wells Fargo is bullish on these five stocks heading into the new year
Wells Fargo analysts are looking ahead to 2024, spotting stocks that might make good buying opportunities. The firm recently called out several
Morgan Stanley’s Mike Wilson on Magnificent 7 in 2024
Much of the gains in the S & P 500 this year can be attributed to the “Magnificent Seven” stocks. The group
Alzheimer’s drug Leqembi shows promise as injection
Eisai on Wednesday said an injectable version of the Alzheimer’s drug Leqembi showed promising initial results in a clinical trial, potentially paving
No More Posts Available.
No more pages to load.